Article Link: Genmab Announces U.S. FDA Approval of Darzalex (daratumumab) in Combination with Pomalidomide and Dexamethasone for Relapsed or Refracto...
Ipsen Announces FDA approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Article Link: Ipsen Announces FDA approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults &#...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
Article Link: Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe Source: FDA New Dru...
FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas
Article Link: FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas ...
FDA Approves Two-Month Aristada for Treatment of Schizophrenia
Article Link: FDA Approves Two-Month Aristada for Treatment of Schizophrenia Source: FDA New Drug Approvals
Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%
Article Link: Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24% Source: FDA New Drug Approvals
Merck Receives FDA Approval of Isentress HD (raltegravir), a New Once-Daily Option for the Combination Treatment of HIV-1 Infection in Appropriate Patients
Article Link: Merck Receives FDA Approval of Isentress HD (raltegravir), a New Once-Daily Option for the Combination Treatment of HIV-1 Infection in A...
FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature
Article Link: FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature ...
Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis
Article Link: Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis Source: FDA New Dr...
FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis
Article Link: FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis Source: FDA New Drug Appro...
